Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì
  #1  
Ñòàðûé 16.04.2022, 23:48
Geda Geda âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 21.05.2018
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5
Ñêàçàë(à) ñïàñèáî: 2
Geda *
Àôñ + âàðôàðèí, ãèïåðïëàçèÿ + êðîâîòå÷åíèÿ. Ìèðåíà?

Çäðàâñòâóéòå!
Âîçðàñò 45. Ðîñò 178, âåñ 82-85. Äèàãíîç ÀÔÑ âûñòàâëåí áîëüøå 10 ëåò íàçàä, ïîñëå ÒÝËÀ è íåîäíîêðàòíî ïîäòâåðæä¸í. Òàê æå ãåòåðîçèãîòíûå ìóòàöèè â ôîëàòíîì öèêëå, äåôèöèò ïðîòåèíà Ñ, ãåòåðîçèãîòà â ôàêòîðå Õàãåìàíà.
Ïðîÿâëÿåòñÿ ÀÔÑ ðåöèäèâèðóþùèìè òðîìáîôëåáèòàìè, áûëà ÒÝËÀ(ìàññèâíàÿ, 2011 ãîä), ïåðåâÿçàíû ÁÏÂ íà îáåèõ íîãàõ.Ñîîòâåòñòâåííî ÏÔÒÑ, âåíîçíàÿ íåäîñòàòîñíîñòü. Ïîñòîÿííî ïðèíèìàþ âàðôàðèí + àñïèðèí. Êîìïðåññèÿ 2 êëàññ.
Ãèíåêîëîãèÿ - 1 áåðåìåííîñòü, 1 ðîäû (2006), âî âðåìÿ áåðåìåííîñòè, áûëî äâà òðîìáîôëåáèòà ïîâåðõíîñòíûõ âåí, áûë ãåñòîç.
Ñåé÷àñ - àäåíîìèîç, äâà íåáîëüøèõ ìèîìàòîçíûõ óçëà, ãèïåðïëàçèÿ ýíäîìåòðèÿ, áûëè ïîëèïû. Çà ïîñëåäíèå 4 ãîäà - 3 ÐÄ ïî ïîâîäó àíîìàëüíîãî ìàòî÷íîãî êðîâîòå÷åíèÿ, äâàæäû áûëè ïîëèïû, ïîñëåäíåå ÐÄ ôåâðàëü 2022, ãèñòîëîãèÿ - æåëåçèñòàÿ ãèïåðïëàçèÿ áåç àòèïèè. Ìåñÿ÷íûå âñå âðåìÿ íà âàðôàðèíå ÷ðåçâû÷àéíî îáèëüíûå ïðè íóæíûõ çíà÷åíèÿõ ÌÍÎ (2-3). Ìåñÿ÷íûå âñåãäà áûëè îáèëüíûìè, íî ïîñëåäíèå ëåò 5 ÿ íå ìîãó âûõîäèòü èç äîìà íà 2-3-4 äåíü, ïðèõîäèòñÿ èñïîëüçîâàòü óðîëîãè÷åñêèå òðóñû. Öèêë 24-26 äíåé, ìåñÿ÷íûå 7-8 äíåé, Ãåìîãëîáèí íå ïîäíèìàåòñÿ âûøå 100, ôåððèòèí è æåëåçî äàëåêè îò íîðìàëüíûõ çíà÷åíèé. Ïðèíèìàþ ïîñòîÿííî ïðåïàðàòû æåëåçà, ïåðåîäè÷åñêè ìåíÿÿ äâóõâàëåíòíîå íà òðåõâàëåíòíîå è îáðàòíî, ïëþñ ôîëèåâóþ êèñëîòó.
Èç ñîïóòñòâóþùèõ ÄÒÇ, ãèïåðòèðåîç, ñåé÷àñ ðåöèäèâ. Íàäåþñü â ýòîì ãîäó ïîïàñòü íà ðàäèéîä.
Ìèãðåíè ñ àóðîé ïðèñóòñòâîâàëè, íî íà âàðôàðèíå ñâåëèñü ê ìàêñèìóì 1 ñëó÷àþ â ãîä. Äàâëåíèå 135-140/80-90 â ñîñòîÿíèè òèðåîòîêñèêîçà. Îáû÷íûå öèôðû 110-120/70-80. Áðàäèêàðäèÿ(âíå òèðåîòîêñèêîçà)
Ñîáñòâåííî âîïðîñ - ìîæíî Ìèðåíó? Èíà÷å ïðåäëàãàþò òîëüêî óäàëÿòü îðãàí, ïîêà íå õîòåëîñü áû, ó÷èòûâàÿ ÷òî áîëüøîé âîïðîñ ñ âîçìîæíîñòüþ ÇÃÒ. Ìîÿ âðà÷ â êîíñóëüòàöèè ñîìíåâàåòñÿ íàñ÷¸ò ìèðåíû èç-çà àôñ, íî ãîâîðèò, ñ óäîâîëüñòâèåì ïîñòàâèò ïî ãèíåêîëîãè÷åñêèì ïîêàçàíèÿì.
Ñïàñèáî!
ÓÇÈ îò ôåâðàëÿ 22 è ðåçóëüòàòû ãèñòåðîñêîïèè è ãèñòîëîãèè, çàêëþ÷åíèå ðåâìàòîëîãà íîÿáðü'11 è ÎÀÊ îò ìàðòà 22.
Ìèíèàòþðû
Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: Screenshot_2022-04-16-23-33-50-975_com.programmisty.emiasapp.jpg
Ïðîñìîòðîâ: 108
Ðàçìåð:	397.6 Êá
ID:	232143  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: IMG_20220416_233439.jpg
Ïðîñìîòðîâ: 32
Ðàçìåð:	321.0 Êá
ID:	232144  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: IMG_20220416_233605.jpg
Ïðîñìîòðîâ: 33
Ðàçìåð:	434.1 Êá
ID:	232145  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: IMG_20220416_234102.jpg
Ïðîñìîòðîâ: 33
Ðàçìåð:	1.72 Ìá
ID:	232146  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: IMG_20220416_234426.jpg
Ïðîñìîòðîâ: 26
Ðàçìåð:	350.1 Êá
ID:	232147  

Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 18.04.2022, 13:54
Geda Geda âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 21.05.2018
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5
Ñêàçàë(à) ñïàñèáî: 2
Geda *
Äîáàâèëà åù¸ ãîðìîíû. Îêòÿáðü 21, âòîðàÿ ïîëîâèíà öèêëà, áëèæå ê mens.
Ìèíèàòþðû
Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: IMG_20220418_135100.jpg
Ïðîñìîòðîâ: 24
Ðàçìåð:	281.3 Êá
ID:	232211  
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 04.05.2022, 17:41
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,206
Ïîáëàãîäàðèëè 33,155 ðàç(à) çà 31,506 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
åñëè åùå èíòåðåñíî, òî ìîæíî, íî (!) íå ó âñåõ óëó÷øåíèå íà ôîíå Ìèðåíû - öèôðû ñðåäè 17 ðåñïîíäåíòîê íà Ìèðåíå è âàðôàðèíå:

The questionnaire was sent to 23 patients and returned by 17.

The amount of bleeding was reduced with the LNG-IUS in 10 (58.8%) women;
amenorrhea occurred in four (23.5%),
no change in blood loss in one (5.9%) and
greater blood loss in two (11.8%) patients.

The number of sanitary pads used was less in 12 (70.6%) patients;
same in one (5.9%) patient,
more in two (11.8%) patients and
two (11.8%) did not remember.

Five patients (29.4%) had shorter duration of bleeding,
four (23.5%) had amenorrhoea,
four (23.5%) had longer periods and
four (23.5%) had same duration by subjective assessment.

Eight (47.1%) patients felt very satisfied,
four (23.5%) felt satisfied,
two (11.8%) felt dissatisfied with the treatment,
one felt very dissatisfied (5.9%) and
two (11.8%) did not respond to the question.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 04.05.2022, 17:48
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,206
Ïîáëàãîäàðèëè 33,155 ðàç(à) çà 31,506 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
åùå: ïîëîæèòåëüíàÿ äèíàìèêà ÷åðåç 3 ìåñ., íî íå áåç ðèñêà îñëîæíåíèé

40 women with HMB receiving VKAs after cardiac valve replacement. Patients were randomly assigned to LNG-IUS or to a no-treatment group. In the LNG-IUS group, there was a significant decrease in the pictorial blood assessment chart bleeding score and the number of bleeding days per cycle at 3 and 6 months compared with baseline pre-insertion, whereas no change was noted in the control group. The mean of hemoglobin and ferritin levels were significantly increased at 3 months but not at 6 months in those randomly assigned to LNG-IUS.

LNG-IUS may increase pelvic pain and breast tenderness.
Breakthrough bleeding often occurs in the first 3 to 6 months.
Other serious but rare complications of LNG-IUS include pelvic infection, device expulsion, and uterine perforation.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 02.09.2022, 19:26
Geda Geda âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 21.05.2018
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5
Ñêàçàë(à) ñïàñèáî: 2
Geda *
Ñïàñèáî! ß óñïåëà ïåðåíåñòè åù¸ îäíî âûñêàáëèâàíèå ñ ìàÿ, òåïåðü íà ãèñòîëîãèè ïîëèï. Ìèðåíó âðà÷è ñòàâèòü îòêàçàëèñü, îïàñàþòñÿ íåïðåäñêàçóåìîñòè ïîñëåäñòâèé. Êàê âàðèàíò ïðåäëîæèëè àáëÿöèþ(àáëàöèþ) ýíäîìåòðèÿ. Âåðíåå, ýòî ìíå ïîñëå âûñêàáëèâàíèÿ âðà÷ ïîñîâåòîâàëà, à ìîÿ ëå÷àùàÿ âðà÷ ñ ýòèì ñîãëàñèëàñü. Ãîòîâëþñü ê îïåðàöèè. Àáëÿöèÿ ìîæåò ñòàòü ðåøåíèåì ìîåé ñèòóàöèè? Ïîñëåäíÿÿ ìåíñòðóàöèÿ îïÿòü 14 äíåé, è ýòî âñåãî ÷åðåç 1 öèêë ïîñëå âûñêàáëèâàíèÿ (((
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 02.09.2022, 21:09
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,206
Ïîáëàãîäàðèëè 33,155 ðàç(à) çà 31,506 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
â óìåëûõ ðóêàõ 10-20% íåóñïåõà, ó âàøèõ ìîæåò áûòü è âûøå

Endometrial ablation plays an important role in the management of heavy menstrual bleeding, but there is an associated 10–20% failure rate

ïîòîì - ãèñòåðåêòîìèÿ

18.8% of patients still needed a hysterectomy after EA.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 06.09.2022, 15:33
Geda Geda âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 21.05.2018
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5
Ñêàçàë(à) ñïàñèáî: 2
Geda *
Ñïàñèáî! Ïî ñóòè òîò æå ïðîöåíò íåóäà÷è, êàê è ñî ñïèðàëüþ, íó ïðè óñëîâèè óìåëûõ ðóê. Íî, êàê ÿ ïîíèìàþ, è âàðèàíòîâ ó ìåíÿ îñîáî íå îñòà¸òñÿ? ß áåçóìíî óñòàëà îò ýòèõ êðîâîòå÷åíèé( . Ïðè ýòîì è ãèñòåðýêòîìèÿ äëÿ ìåíÿ òîæå ñïîðíîå ðåøåíèå, â âèäó ðèñêà ðåöåäèâà òýëà, îñîáåííî, åñëè âûïîëíÿòü ÷åðåç áðþøíóþ ñòåíêó, ÿ ïðàâèëüíî ïîíèìàþ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 06.09.2022, 16:59
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,206
Ïîáëàãîäàðèëè 33,155 ðàç(à) çà 31,506 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ìîæåò è òàê, íî ñïèðàëü - åòî íå àáëàöèÿ, åñëè ó âàñ çàáîëåëà ãîëîâà, òî Âû íà÷í¸òå ñ òàáëåòîê èëè ñðàçó ãèëüîòèíà?
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 06.09.2022, 17:04
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,206
Ïîáëàãîäàðèëè 33,155 ðàç(à) çà 31,506 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ïîñìîòðèòå êàðòèíêó 1 êàê âåäóò òàêèõ ïàöèåíòîâ; õèðóðãèÿ òîëüêî = êîãäà íåò ýôôåêòà îò ëåêàðñòâ

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 06.09.2022, 17:56
Geda Geda âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 21.05.2018
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5
Ñêàçàë(à) ñïàñèáî: 2
Geda *
Òàê ñïèðàëü îíè îòêàçûâàþòñÿ ìíå ñòàâèòü, íå ìîæåì áðàòü íà ñåáÿ ðèñê, ïîòîìó ÷òî âåðîÿòíîñòü òðîìáîçà èìååòñÿ. Íî ÿ, êîíå÷íî, åù¸ ðàç ïîïðîáóþ äî îïåðàöèè ïîëó÷èòü êîíñóëüòàöèþ åù¸ ó îäíîãî âðà÷à. Ñïàñèáî çà èíôîðìàöèþ!
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 06.09.2022, 19:03
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,206
Ïîáëàãîäàðèëè 33,155 ðàç(à) çà 31,506 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
íåò, íà ìèðåíå ñ ëåâîíîðãåñòðåëîì ðèñê òðîìáîçà îòðèöàòåëüíûé; à âîò æä àíåìèÿ ïîâûøàåò ðèñê òðîìáîçà
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò


Îïöèè òåìû Ïîèñê â ýòîé òåìå
Ïîèñê â ýòîé òåìå:

Ðàñøèðåííûé ïîèñê
Îïöèè ïðîñìîòðà

Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 14:05.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.